Department of Medicine

February 9, 2026

Vanderbilt research uncovers new clue to insulin resistance

The latest findings could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.

By Bill Snyder
February 6, 2026

New analytical approach identifies novel risk genes for colorectal cancer

The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

By Leigh MacMillan
February 5, 2026

‘Liberation’ from acute dialysis may enhance recovery of kidney function

Researchers at Vanderbilt Health and three other centers compared conventional dialysis to a conservative dialysis strategy.

By Guillermo Sanchez, PhD
February 4, 2026

Vanderbilt Health’s Vineet Agrawal, Fabian Bock among 2026 ASCI Young Physician-Scientist awardees

Since 2014, 27 Vanderbilt faculty members have received the annual award, which recognizes “notable achievements” by researchers early in their first faculty appointments.

By Bill Snyder
(iStock)
February 4, 2026

Clinical trial led by Vanderbilt Health seeks to refine lung cancer biopsy standards

The development of better biopsy approaches is driven by the fact that lung cancer kills more than 130,000 Americans annually, and survival depends on early diagnosis, which requires biopsy to be definitive.

By Jill Clendening
Stokes Peebles, MD, right, Mark Rusznak, PhD, and their colleagues have identified a potential drug target for treating asthma. (photo by Erin O. Smith)
February 4, 2026

Broad genetic study reveals new drug target for asthma

The findings could bring relief to the more than 26 million people in the United States with asthma, a chronic and complex inflammatory disease of the airways.

By Bill Snyder
January 28, 2026

Gut microbiome differs according to C. diff symptom status

In a study of children with symptomatic or asymptomatic C. diff, symptom status loomed as the strongest association with differences in gut microbial abundance and diversity.
By Paul Govern
January 20, 2026

VIGH, Ugandan partners land grant to study bunyaviruses in Tennessee and Uganda

Bunyaviruses can lead to many illnesses, ranging from mild fevers to serious and sometimes deadly diseases such as hemorrhagic fevers and encephalitis in both children and adults.
By Kristin Centers
January 16, 2026

Study finds so-called super agers tend to have at least two key genetic advantages

Super agers were 68% less likely to harbor the gene nobody wants,APOE-ε4, compared to individuals with AD dementia in the same 80+ age group.
By Paul Govern
January 15, 2026

Immunometabolism may be a key to controlling sepsis: study

This discovery may lead to new ways to block metabolic changes contributing to excessive and ineffective inflammation, reset the immune system, and bring sepsis under control.
By Bill Snyder
January 14, 2026

Vanderbilt Transplant Center nation’s largest after performing record number of solid organ transplants in 2025

Through dramatic growth, the VTC is now the largest transplant center in the country by volume, according to data from the United Network for Organ Sharing.
By Matt Batcheldor
January 12, 2026

Pablo Juárez named president-elect of the Association of University Centers on Disabilities

Juárez’s election to this role reflects his long-standing commitment to innovation in the field of intellectual and developmental disabilities.
January 12, 2026

Guide published for outpatient cancer treatment with bispecific antibodies

Vanderbilt-Ingram was among the first in the nation to establish outpatient protocols for another personalized immunotherapy, CAR-T.
By Tom Wilemon